Lower Fluorescein Sodium Dose on Confocal Laser Endoscopy Image Quality and Yellow Discoloration of the Skin
NCT02519920 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 63
Last updated 2015-10-20
Summary
This study was to test an appropriate dose of fluorescein sodium which can provide high image quality to ensure endoscopy examination and have no yellow dye in the skin by a randomized blinded controlled trial.
Conditions
- Image Quality
- Skin Discoloration
Interventions
- DRUG
-
fluorescein sodium 0.01ml/kg
fluorescein Sodium Dose of 0.01ml/kg on confocal laser endoscopy image quality and yellow discoloration of the skin
- DRUG
-
fluorescein sodium 0.02ml/kg
fluorescein Sodium Dose of 0.02ml/kg on confocal laser endoscopy image quality and yellow discoloration of the skin
- DRUG
-
fluorescein sodium 0.05ml/kg
fluorescein Sodium Dose of 0.05ml/kg on confocal laser endoscopy image quality and yellow discoloration of the skin
- DRUG
-
fluorescein sodium 0.1ml/kg
fluorescein Sodium Dose of 0.1ml/kg on confocal laser endoscopy image quality and yellow discoloration of the skin
Sponsors & Collaborators
-
Shandong University
lead OTHER
Principal Investigators
-
Yanqing Li, PhD.MD · Department of Gastroenterology,Qilu Hospital,Shandong University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- China
Study Locations
More Related Trials
-
Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation
NCT01404845 ·Status: COMPLETED ·Phase: NA
-
Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration
NCT01048476 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Antioxidant Systems and Age-Related Macular Degeneration
NCT00668213 ·Status: COMPLETED
-
Relationships Between Macular Pigment Optical Density and Lacquer Cracks in High Myopic Patients.
NCT02205632 ·Status: COMPLETED ·Phase: NA
-
Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome
NCT00004345 ·Status: TERMINATED
-
Oxidative Stress in Patients With Age-Related Macular Degeneration
NCT00465400 ·Status: COMPLETED
-
FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment
NCT04761341 ·Status: COMPLETED ·Phase: PHASE4
-
The Zeaxanthin and Visual Function Study
NCT00564902 ·Status: COMPLETED ·Phase: NA
-
Effects of Lutein in Retinitis Pigmentosa
NCT00029289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60
NCT00121589 ·Status: COMPLETED ·Phase: PHASE1
-
Omega-3-fatty Acids on Age-related Macular
NCT01258335 ·Status: COMPLETED ·Phase: NA
-
Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation
NCT02264938 ·Status: COMPLETED ·Phase: NA
-
Omega 6:Omega 3 Ratio and Progression of Age-related Macular Degeneration (AMD).
NCT00987129 ·Status: TERMINATED
-
Effect of OMEGA3 Supplementation in Diabetic Retinopathy
NCT04499820 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration.
NCT05056025 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness
NCT02321189 ·Status: UNKNOWN ·Phase: NA
-
Association of MPOD Values With Blue Light.
NCT04779398 ·Status: COMPLETED
-
MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin
NCT00568828 ·Status: UNKNOWN
-
To Study the Effects of Baby Drink on Vision Care
NCT05778201 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD
NCT04482465 ·Status: COMPLETED ·Phase: NA
-
Macular Pigment Measurements in Eye & Other Tissues
NCT03022773 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
NCT01521793 ·Status: COMPLETED ·Phase: PHASE1
-
Lutein by Scleral Iontophoresis in AMD
NCT06925893 ·Status: RECRUITING
-
Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy
NCT01627977 ·Status: COMPLETED ·Phase: PHASE3
-
Retinoic Acid Supplementation and Subjects With Hypercholesterolemia
NCT02497833 ·Status: COMPLETED ·Phase: EARLY_PHASE1